{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:42:44Z","timestamp":1793497364440,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019139","name":"Life Sciences, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","award":["219535"],"award-info":[{"award-number":["219535"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rmed.2025.108172","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:13:09Z","timestamp":1748430789000},"page":"108172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative effectiveness of inhaled fluticasone propionate\/salmeterol and budesonide\/formoterol fixed-dose combinations in asthma control \u2013 a retrospective United States database analysis"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3087-9530","authenticated-orcid":false,"given":"Nicola A.","family":"Hanania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-4024","authenticated-orcid":false,"given":"Adrian","family":"Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5953-4881","authenticated-orcid":false,"given":"Bilun","family":"Gemicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Fritscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0143-2609","authenticated-orcid":false,"given":"Watchara","family":"Boonsawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurita","family":"Mamjudar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-4600","authenticated-orcid":false,"given":"Nnaemeka","family":"Odo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108172_bib1","series-title":"World Health Organization","article-title":"Asthma","year":"2024"},{"key":"10.1016\/j.rmed.2025.108172_bib2","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.5888\/pcd21.240005","article-title":"The status of asthma in the United States","volume":"21","author":"Pate","year":"2024","journal-title":"Prev. Chronic Dis."},{"issue":"9","key":"10.1016\/j.rmed.2025.108172_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201901-0016OC","article-title":"The projected economic and health burden of uncontrolled asthma in the United States","volume":"200","author":"Yaghoubi","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108172_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pupt.2017.09.001","article-title":"Comparison of fluticasone\/formoterol with budesonide\/formoterol pMDI in adults with moderate to severe persistent asthma: results from a 12-week randomized controlled trial","volume":"48","author":"Balki","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.rmed.2025.108172_bib6","first-page":"CD004106","article-title":"Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children","author":"Lasserson","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.rmed.2025.108172_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.rmed.2006.03.001","article-title":"EXCEL: a randomised trial comparing salmeterol\/fluticasone propionate and formoterol\/budesonide combinations in adults with persistent asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108172_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106993","article-title":"Impact of inhaled fluticasone propionate\/salmeterol on health-related quality of life in asthma: a network meta-analysis","volume":"203","author":"Maneechotesuwan","year":"2022","journal-title":"Resp Med"},{"issue":"1","key":"10.1016\/j.rmed.2025.108172_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12931-024-03084-7","article-title":"Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS\/LABA combinations in asthma management","volume":"26","author":"Park","year":"2025","journal-title":"Resp Res"},{"issue":"3","key":"10.1016\/j.rmed.2025.108172_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","article-title":"Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists","volume":"117","author":"Schatz","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108172_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/02770903.2019.1663429","article-title":"Medication adherence in patients with asthma using once-daily versus twice-daily ICS\/LABAs","volume":"58","author":"Averell","year":"2021","journal-title":"J. Asthma"},{"issue":"8","key":"10.1016\/j.rmed.2025.108172_bib13","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1007\/s12325-024-02914-w","article-title":"A simulation study of the effect of clinical characteristics and treatment choice on reliever medication use, symptom control and exacerbation risk in moderate\u2013severe asthma","volume":"41","author":"Garcia","year":"2024","journal-title":"Adv. Ther."},{"issue":"10","key":"10.1016\/j.rmed.2025.108172_bib14","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1007\/s12325-023-02590-2","article-title":"Understanding the clinical implications of individual patient characteristics and treatment choice on the risk of exacerbation in asthma patients with moderate\u2013severe symptoms","volume":"40","author":"Singh","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2025.108172_bib15","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.2147\/DDDT.S266177","article-title":"Budesonide\/formoterol anti-inflammatory reliever and maintenance or fluticasone propionate\/salmeterol plus as-needed, short-acting \u03b22 agonist: real-world effectiveness in patients without optimally controlled asthma (REACT) study","author":"Cheng","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2025.108172_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053964","article-title":"Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study","volume":"12","author":"Sicras-Mainar","year":"2022","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.rmed.2025.108172_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2008.03.019","article-title":"Comparison of adjustable-and fixed-dose budesonide\/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate\/salmeterol dry powder inhaler in asthma patients","volume":"121","author":"Busse","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2025.108172_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-8-46","article-title":"Salmeterol\/fluticasone stable-dose treatment compared with formoterol\/budesonide adjustable maintenance dosing: impact on health-related quality of life","volume":"8","author":"Price","year":"2007","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.rmed.2025.108172_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaip.2014.07.016","article-title":"Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis","volume":"2","author":"Tunceli","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2025.108172_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2024.09.021","article-title":"The role of biologics in inducing remission in asthma","volume":"134","author":"Busse","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108172_bib21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2025.108172_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcrc.2016.07.017","article-title":"Immortal time bias in observational studies of time-to-event outcomes","volume":"36","author":"Jones","year":"2016","journal-title":"J. Crit. Care"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:34:34Z","timestamp":1764920074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125002343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"alternative-id":["S0954611125002343"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108172","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of inhaled fluticasone propionate\/salmeterol and budesonide\/formoterol fixed-dose combinations in asthma control \u2013 a retrospective United States database analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 GSK. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108172"}}